Himax Technologies, Inc., a fabless semiconductor company, provides display imaging processing technologies in China, Taiwan, Korea, Japan, the United States, Mexico, and internationally.
FAIL · Does not pass the screen
11.32 USD
Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 7 days ago
Screened 2026-10-23 · the tape above runs as of 06:02 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
Price11.32 USD at the 23 Oct 2026 close
Ethical screenDoes not pass
OptionsOpen interest leans heavily to calls (put/call 0.67)
Last reviewed23 Oct 2026 (7 days ago)
A summary of the dated readings below, not a live quote and not advice.
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 11.32 against the desk's fair-value range, base estimate 15.28, over the last year.
Positioning no disclosures inside 60 days, left as found
Options put/call open interest 0.67, read 2026-10-28
Ethical does not pass the values gate
Price11.32 USD
Fair value15.28
Ethical score70.0/100
Our investment reviews on this name
2026-10-18Read Markdown12.67-10.7% to today ✓Distribution gives way to Markdown after a 17% slide in 7 days
2026-10-11Read Distribution15.24-25.7% to today ✓Accumulation gives way to Distribution
2026-10-02Read Accumulation14.61-22.5% to today Markup gives way to Accumulation after a 6% rise in 5 weeks
2026-08-31Read Markup13.84-18.2% to today Distribution gives way to Markup after an 8% rise in 4 weeks
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
Himax Technologies, Inc. holds its Markdown at $11.32. The statistical read favours the sellers, held for 35 days.
As held on the ledger · 2026-10-23
Phase
Markdown · caution
Quantitative state
The statistical read favours the sellers, held for 35 days
Price at the screen
$11.32
Valuation
56.43 trailing · 9.12 forward price to earnings
Values screen
FAIL· score 70.0
Beta
2.40
The Workings
Five Screens, Shown in Full
Does not pass. Debt ratio
Test
Figure
Limit
What it means
Status
Business activity
Permissible
Core business clean
Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending.
Pass
Debt load
34.50%
Below 33%
Interest-bearing debt is 34.5% of its assets, above the one-third ceiling the screen allows.
Fail
Interest-bearing cash
3.28%
Below 33%
Cash held in interest-bearing accounts and securities is 3.3% of assets, under the one-third limit.
Pass
Receivables
26.42%
Below 49%
Money owed to the company is 26.4% of assets, under the 49% limit.
Pass
Revenue purity
1.18%
Below 5%
Only 1.2% of revenue comes from non-compliant sources, under the 5% line.
Pass
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical Read
Why It Falls Short, in Plain English
Himax Technologies,'s business is in a permissible area, but its interest-bearing debt is about 35% of the company, just over the ~33% line, so it does not pass on the financial screens.
Read as at 2026-10-29. It updates when the underlying figures move, and past reads are kept below.
Follow this verdict
Get an email when HIMX's ethical verdict changes
Today HIMX does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. A 35.0% margin of safety to the base estimate.
Third-party analyst targets: 2 covering, consensus Buy. The average target sits +167% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & Projections
Where it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words
Display chips hit a familiar cyclical wall
Every time a new phone screen flickers on in Asia, Himax supplies the driver chips that make the image work. Yet the company is posting falling revenue, single-digit margins and a return on equity stuck at 4 percent, which is why the opportunity rating sits at none despite a forward multiple of just 12.8 times and an ethical screen that clears.
The low multiple looks tempting until the cyclical nature of the semiconductor business is factored in. Peak earnings often arrive with the highest volumes and then collapse, leaving investors holding a cheap stock that stays cheap for years. Here the numbers already show an 8 percent revenue decline, so the valuation offers little protection once the cycle turns.
Currency swings, customer concentration in a few handset makers and an unknown competitive moat add further uncertainty. The market is correctly treating this as a business that can deliver thin returns for long stretches rather than a bargain hiding in plain sight. Analysis, not advice.
The risks · The things to watch: it already moves more than the market on an average day; its business and earnings are exposed to Taiwan and to currency swings.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to Trade
HIMX trades on Nasdaq (the company is based in Taiwan). As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
The Dated Journal · Newest First, Never Edited
Every Entry, As Written
2026-10-25Markdown$11.85-6.5%Entry 9
The analysis reads markdown. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 6.5% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 4% above its long-term trend line with momentum reading oversold. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (2 analysts) rates it none, with a mean price target of $24.
2026-10-18Markdown · changed$12.67-16.9%Entry 8
The framework has shifted from distribution to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 16.9% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 121% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (2 analysts) rates it none, with a mean price target of $24.
The framework has shifted from accumulation to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved up 4.3% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it C. Technically it is holding around 121% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (2 analysts) rates it none, with a mean price target of $24.
The framework has shifted from markup to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 5.6% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 121% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (2 analysts) rates it none, with a mean price target of $24.
2026-08-31Markup · changed$13.84+8.1%Entry 5
The framework has shifted from distribution to markup since the last review. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved up 8.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 121% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (2 analysts) rates it none, with a mean price target of $24.
The framework has shifted from markup to distribution since the last review. Smart money appears to be selling into strength. Institutional holders may be rotating out. Price has moved down 27.7% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows good risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 121% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (2 analysts) rates it none, with a mean price target of $24.
2026-07-18Markup$17.70+0.0%Entry 3
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 121% above its long-term trend line with momentum reading bullish. Over the past year the shares are up 90%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (2 analysts) rates it none, with a mean price target of $24.
2026-07-03Markup$17.70+0.0%Entry 2
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Price has moved down 0.0% since our last review. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02Markup$17.70Entry 1
Our analysis reads markup. Price is trending higher with momentum. The crowd has caught on and buyers are in control. Ethical screening: PASS with passing ethical screen (70). The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
